Skip to content
Venture Capital

Connetic Venture Capital Access Fund

Formation2023
CategoryInterval Fund
Net Assets

$44.7M

NAV YoY

N/A

Portfolio Composition

Investment Type

Common Stock in Private Companies
2.40%
Preferred Stock in Private Companies
32.20%
Simple Agreement for Future Equity in Private Companies
29.70%
Convertible Note in Private Companies
23.70%
Exchange Traded Funds
9.30%
Common Stock in Public Companies
0.00%
Derivative in Public Companies
0.00%
Short-Term Investments
2.40%
Other assets in excess of liabilities
0.30%

Geography

North America
59.40%
Europe
4.80%
Global
27.00%
Other
8.80%

Strategy

Pre-Seed
28.13%
Seed
57.29%
Series A
9.38%
Public & Secondary Market
5.21%

Portfolio composition data sourced from regulatory filings.

Sekond Intelligence

Liquidity RiskB+
Fee Impact1.45%
Quality of Return1.6x

Deeper Analysis

Institutional intelligence and portfolio transparency

Reported as of September 2025

Principal Portfolio Holdings

HoldingValueAllocation
Cary Rx Inc. - Cary Rx Inc.2
$4.8M10.67%
Get Bizzy, Inc. - Get Bizzy, Inc. (Seed)
$3.9M8.71%
Cary Rx Inc.
$3.1M7.03%
Proprietary Exposure
------
Proprietary Exposure
------

Showing 3 of 109 holdings. Pro access required for full portfolio disclosure.

Upgrade to Pro Analysis

Complete Intelligence Layer

Unlock deeper insights including Peer Benchmarking, Historical Performance Attribution, Fee Structure Analysis, and Liquidity Stress Models.

Contact for Firm-Wide Access

About This Fund

The Connetic Venture Capital Access Fund is a '40 Act registered closed-end investment company operating as an interval fund managed by Connetic RIA LLC. It focuses on equity securities of early-stage private venture capital investments, primarily targeting North American technology companies with additional exposure to consumer products and consumer discretionary sectors. The fund utilizes proprietary AI-driven screening technology called Wendal and offers quarterly repurchase opportunities at net asset value for liquidity.